Skip to content
OpenCapital
Get started

Danaher DHR Life Sciences — Intangible Amortization

Similar metrics at other companies

PTC Therapeutics logo
PTCTLife Science — Intangible Amortization
$11.58M+205%
Bio-Rad Laboratories logo
BIOLife Science — Depreciation, Depletion and Amortization
$18.3M+7.6%
Ashland logo
ASHLife Sciences — Adjustment For Amortization
$5M+25.0%
VAT
VATELife Sciences — D&A
$100K0.0%
Opko Health logo
OPKPharmaceutical — Intangible Amortization
$16.44M+0.1%
Methode Electronics logo
MEIMedical — Intangible Amortization
$0—

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's life sciences — intangible amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's life sciences — intangible amortization?
Danaher (DHR) reported life sciences — intangible amortization of $151M in Q2 2026.
How has Danaher's life sciences — intangible amortization changed year-over-year?
Danaher's life sciences — intangible amortization increased by 0.7% year-over-year, from $150M to $151M.
What is the long-term trend for Danaher's life sciences — intangible amortization?
Over 3 years (2022 to 2025), Danaher's life sciences — intangible amortization has grown at a 13.0% compound annual growth rate (CAGR), from $419M to $604M.
What does life sciences — intangible amortization mean?
The periodic expense recognized for the consumption of intangible assets, such as patents, trademarks, and acquired technology, within the Life Sciences segment. This reflects the cost of intellectual property acquired through business combinations. It is essential for understanding the true economic cost of maintaining a competitive technological advantage.